Bellicum Pharmaceuticals Stock Forecast
Recent Bellicum Pharmaceuticals Stock Price |
|
Bellicum Pharmaceuticals Stock Forecast Price |
$0.00 |
NA% |
$0.00 |
As of
Recent Bellicum Pharmaceuticals Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
|
|
|
|
Buy ratings: |
|
|
|
|
Hold ratings: |
|
|
|
|
Sell ratings: |
|
|
|
|
Strong sell ratings: |
|
|
|
|
Average rating: |
|
|
|
|
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
The presented Bellicum Pharmaceuticals stock forecast (traded under symbol BLCM), for forward-twelve-months price target as shown at the top of this page, gives you the average Bellicum Pharmaceuticals stock forecast for forward target price for symbol BLCM, across the analysts covering Bellicum Pharmaceuticals (BLCM), as reported in
data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Bellicum Pharmaceuticals stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Bellicum Pharmaceuticals stock forecast and half had a lower Bellicum Pharmaceuticals stock forecast) was $ as of (which is a different mathematical metric versus taking the average or mean), while the
highest Bellicum Pharmaceuticals stock forecast in the analyst group was $, and the lowest Bellicum Pharmaceuticals stock forecast in the analyst group was
$, with a standard deviation of $. Get the latest Zacks research report on BLCM — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
May 1, 2024 7:14 AM Eastern
Hold (2.00 out of 4)
100th percentile
|
|